Comments
Alembic Ltd.’s share price went down by 0.30 per cent after the company reported a recall of its products in the US market due to manufacturing problems, as written by the US Food and Drug Administration (USFDA).
The recall affects 12,336 bottles of Buprenorphine Sublingual tablets, used for treating opioid use disorder, and 2,844 units of Diclofenac Sodium Topical Solution, used for alleviating pain and arthritis symptoms. The company’s response to the issues is detailed in the most recent Enforcement Report by the USFDA, and the recall aims to protect consumer safety.
The shares of the company went down by 0.30 per cent to ₹82.48 at 09:40 a.m. on BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.